Biocon’s founder and managing director Kiran Mazumdar-Shaw has said the company is ready to slash the cost of recombinant human insulin it sells in low- and middle-income countries by 50% – and possibly more – to 10 cents a day.
Speaking at a UNAIDS Health Innovation function in New York, the self-made billionaire who is one of India’s best-known philanthropists...



